December 21, 2010 -- Hutchison MediPharma, a division of Chi-Med, raised $7.7 million from Softbank China Venture Capital’s SBCVC Fund III. The second investment in the current round of fund raising, SBCVC’s contribution follows a $12.5 million investment from Mitsui & Co. in November. SBCVC Fund III will receive convertible Preference Shares equivalent to 7.5% of Hutchison MediPharma. More details....
